Ketamine
Ketamine is a dissociative anaesthetic medication used for the induction and maintenance of anaesthesia and, in selected settings, for procedural sedation and acute pain management. It works primarily by blocking NMDA receptors in the central nervous system, producing anaesthesia, analgesia, and dissociative effects. It is available as an injectable solution, while specific formulations may be approved for other medical uses in certain countries. Common side effects include nausea, vomiting, dizziness, increased heart rate, elevated blood pressure, and emergence reactions such as confusion or hallucinations. Important risks include respiratory complications, psychological effects, and misuse or dependence with repeated non-medical use. Ketamine should be administered under qualified medical supervision with appropriate monitoring.
Ketamine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Ketamine, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Ketamine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Ketamine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
